Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.
An article joins this feed when it matches these terms. Each one is also a search of its own.
Clinical Anatomy & Kinesiology (CAK) | Project ATLAS Phase 5 Physiology, Pain Science, and Evidence Edition Placebo and nocebo effects are phenomena where expectations, learning, and the treatment context influence the experience of symptoms. This is not a concept that advocates for deceptive…
COVINGTON, LA, UNITED STATES, October 8, 2026 /EINPresswire.com/ — Lanclos 1063, a Louisiana-based private investment house, announces an investment and partnership with AI:ON Innovations (aion.health... Lanclos 1063, LLC Announces Investment in Groundbreaking AI Medical Imaging COVINGTON, LA, UNITED STATES, October 8, 2026 /EINPresswire.com…
While the spotlight often shines brightest on AI’s impact in medicine, its transformative power extends far beyond drug discovery. AI scientific discovery is rapidly reshaping fields like materials science and climate research, opening up entirely new avenues for innovation that…
Dec 02, 2025, 02:25 ET The new analyses indicate that there were fewer countable motor seizures as early as two weeks following bexicaserin treatment initiation and that these reductions were maintained over a full year of open label observation. This observed response was…
BERLIN, Oct 19 (Reuters) - Roche said on Monday it will present new late-stage trial results at the ESMO 2026 cancer meeting in Madrid, including data showing its lung cancer drug divarasib worked better than current KRAS G12C treatments. The... BERLIN, Oct 19 (Reuters) â…
The drug changed the biology in both directions. yet the disease remained unchanged. For about three years, the expectation around GLP-1 drugs has run in one direction. They started as diabetes medicines, turned out to drive weight loss, then showed…
In research on cell therapy products for chronic kidney disease, a key theme is how to secure cells and culture them while maintaining quality. EHL BIO is advancing the development of KIDSTEM®, a candidate cell therapy product based on urine-derived…
PYC Therapeutics shares fell 10.46% ahead of a conference presentation on preliminary PYC-003 data, despite no new clinical results being released on Tuesday. SYDNEY â Shares of PYC Therapeutics fell more than 10 percent on Tuesday, trading at $2.14, down 25 cents, or 10.46 percent,…
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the 2026 European Society for Medical Oncology (ESMO) Annual Meeting, held from October 23 to…
SAN JOSE, CA, UNITED STATES, October 18, 2026 /EINPresswire.com/ — Pharmuna, an AI-powered pharmacy platform designed to make medical and medication-related guidance more accessible, has raised $5 million through FasterCapital. The company had previously secured $200,000 in investment to support its initial development and…